Paperpal Prime Logo

Translational and Clinical Pharmacology : Impact Factor & More

eISSN: 2383-5427pISSN: 2289-0882

Key Metrics

CiteScore
2
H-Index
10
SJR
Q3Pharmacology (medical)
SNIP
0.69
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Translational and Clinical Pharmacology

Translational and Clinical Pharmacology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher KSCPT
Frequency Quarterly
General Details
FrequencyQuarterly
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Translational and Clinical Pharmacology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Translational and Clinical Pharmacology

Comparison of pharmacokinetics and safety of fixed-dose versus loose combination of atorvastatin/fenofibrate 10/145 mg in healthy Korean participants
  • 1 Jun 2026
  • Translational and Clinical Pharmacology
Implementation of decentralized clinical trials in Korea from a resource-based perspective
  • 1 Jun 2026
  • Translational and Clinical Pharmacology
Pharmacokinetics and safety of nafamostat and its metabolites following single- and multiple-dose oral administration of nafamostat mesylate in healthy male participants
  • 1 Jun 2026
  • Translational and Clinical Pharmacology
Development and evaluation of automated screening algorithms for pre-analytical errors in pharmacokinetic data: a simulation-based study
  • 1 Jun 2026
  • Translational and Clinical Pharmacology
Comparative pharmacokinetics of a candesartan/amlodipine/atorvastatin fixed-dose combination 8 mg/5 mg/10 mg versus separate tablets in healthy subjects: a partial replicated crossover study.
  • 1 Mar 2026
  • Translational and clinical pharmacology
Erratum: A review of clinical pharmacology considerations in antibody-drug conjugates approved by the US Food and Drug Administration between 2000 and 2025.
  • 1 Mar 2026
  • Translational and clinical pharmacology
Comparison of pharmacokinetics and safety of fixed-dose versus loose combination of atorvastatin/fenofibrate 10/145 mg in healthy Korean participants
  • 1 Jun 2026
  • Translational and Clinical Pharmacology
Implementation of decentralized clinical trials in Korea from a resource-based perspective
  • 1 Jun 2026
  • Translational and Clinical Pharmacology
Pharmacokinetics and safety of nafamostat and its metabolites following single- and multiple-dose oral administration of nafamostat mesylate in healthy male participants
  • 1 Jun 2026
  • Translational and Clinical Pharmacology
Development and evaluation of automated screening algorithms for pre-analytical errors in pharmacokinetic data: a simulation-based study
  • 1 Jun 2026
  • Translational and Clinical Pharmacology
Comparative pharmacokinetics of a candesartan/amlodipine/atorvastatin fixed-dose combination 8 mg/5 mg/10 mg versus separate tablets in healthy subjects: a partial replicated crossover study.
  • 1 Mar 2026
  • Translational and clinical pharmacology
Erratum: A review of clinical pharmacology considerations in antibody-drug conjugates approved by the US Food and Drug Administration between 2000 and 2025.
  • 1 Mar 2026
  • Translational and clinical pharmacology

FAQs on Translational and Clinical Pharmacology